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ABSTRACT
Polycomb repressive complex 2 (PRC2) is known to play an important role in the 
regulation of early embryonic development, differentiation, and cellular proliferation 
by introducing methyl groups onto lysine 27 of histone H3 (H3K27me3). PRC2 is 
tightly associated with silencing of Hox gene clusters and their sequential activation, 
leading to normal development and differentiation. To investigate epigenetic changes 
induced by PRC2 during differentiation, deposition of PRC2 components and levels 
of H3K27me3 were extensively examined using mouse F9 cells as a model system. 
Contrary to positive correlation between PRC2 deposition and H3K27me3 level, 
down-regulation of PRC2 components by shRNA and inhibition of EZH1/2 resulted in 
unexpected elevation of H3K27me3 level at the Hox gene cluster despite its global 
decrease. We found that metal response element binding transcriptional factor 2 
(MTF2), one of sub-stoichiometric components of PRC2, was stably bound to Hox 
genes. Its binding capability was dependent on other core PRC2 components. A high 
level of H3K27me3 at Hox genes in Suz12-knock out cells was reversed by knockdown 
of Mtf2.This shows that MTF2 is necessary to consolidate PRC2-mediated histone 
methylation. Taken together, our results indicate that expression of Hox gene clusters 
during differentiation is strictly modulated by the activity of PRC2 secured by MTF2.
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INTRODUCTION
Epigenetic events control the expression of lineage-
specific transcription factors by providing permissive or 
repressive environment in the nucleus. Such expression 
is associated with development and differentiation [1]. 
Genome-wide studies have shown that many genes are 
involved in embryonic development. Cell fate decisions 
can be silenced by polycomb group (PcG) proteins through 
H3K27me3 [2]. PcG proteins can restraint differentiation 
of pluripotent stem cells by rectifying histone methylation 
states (mono-, di-, and tri-methylated forms) and bring 
about repression of target genes. These proteins can induce 
and block some specific pathways responsible for the 
differentiation in a cell type-specific manner by controlling 
their target genes’ expression [3–5]. PcG proteins form 
a huge complex called polycomb repressive complex 
(PRC) that oversees transcription of target genes through 
epigenetic histone modifications. Generally, there are two 
major classes of PRC; PRC1 and PRC2. EZH2-containing 
PRC2 complex catalyzes deposition of H3K27me3 at 
target sites to be repressed while PRC1 introduces mono-
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ubiquitination of H2AK119 [6, 7]. Both PRC1 and PRC2 
are involved in fine-tuning of transcriptional activity by 
altering chromatin states of developmentally regulated 
genes. During early embryonic development and ES cells 
differentiation, heterochromatin structure is progressively 
changed to euchromatin with gene expression [8].
The PRC2 complex can be found in two forms 
(PRC2- EZH2 and PRC2- EZH1) with two additional 
core components, SUZ12 and EED [9]. EZH2 is the major 
methyltransferase in the PRC2 complex. In the absence of 
EZH2, EZH1 might compensate for its function [10]. EZH2 
is abundantly expressed in embryonic tissues and dividing 
cells whereas EZH1 is mostly found in non-dividing and 
differentiated cells [10–12]. EZH2 exhibits higher histone 
methyltransferase activity than EZH1 both in vitro and in 
vivo [10, 11]. Although the role of PRC2-EZH2 has been 
relatively well characterized [13, 14], the functional role 
of PRC2-EZH1 is not much explored. EZH2, a catalytic 
subunit of PRC2, is not sufficient for maintaining stem 
cell identity and pluripotency without forming a complete 
complex with other core PRC2 components like SUZ12 and 
EED [8, 10]. In the absence of SUZ12, the expression level 
of EZH2 is severely decreased, and thus the global levels of 
H3K27me3 diminish and cellular proliferation is attenuated 
[15, 16]. Eed knockout embryonic stem (ES) cells can retain 
the ability to differentiate into all three germ layers and form 
chimera. However, without SUZ12, ES cells cannot proceed 
to proper cellular differentiation along with defective gene 
expression essential for stem cell function [16, 17]. 
In Drosophila, PCL (polycomb-like) has been 
identified as an accessory component of PRC2 complex 
[18, 19]. Histone methyl transferase activity of PRC2 is 
enhanced in the presence of PCL [20]. MTF2 or PCL2, a 
mammalian orthologue of PCL, has the same function as 
PCL in Drosophila. MTF2 protein has a Tudor domain and 
two tandem PHD (plant homeodomain) zinc finger motifs 
that are associated with core PRC2 components. MTF 
is uniquely expressed in mouse ES cells and involved 
in early embryonic development and mostly enriched at 
polycomb target genes. MTF2 knockdown increased self-
renewal activity of ES cells and blocked differentiation by 
decreasing H3K27me3 at specific targets [21]. 
Like ES cells, embryonal carcinoma (EC) cells 
have also been widely used as a model system for 
differentiation-related analysis as well as cancer stem 
cell studies. EC cells express majority of ES cell marker 
genes and can be easily grown in a short time by using 
limited resources. Retinoic acid (RA) treatment of EC 
cells induces differentiation into primitive endodermal 
cells by the displacement of PcG proteins and H3K27me3 
on target genes [22–25]. Murine F9 cells are multipotent 
cell lines that can be maintained for a longer time without 
spontaneous differentiation [26, 27]. Similar to ES cells, 
F9 cells can also repress the transcription of exogenous 
retroviral DNAs by epigenetic mechanisms [28]. Despite 
efficient integration of viral sequences into the genome, 
F9 cells are resistant to expression of genes driven by 
viral promoters in undifferentiated state. However, 
differentiation may release this epigenetic repression and 
restore the transcription of viral sequences [29].
In this study, epigenetic changes were carefully 
examined during differentiation of F9 cells. Genome-
wide distribution of H3K27me3 and binding profiles of 
PRC2 components were compared with gene expression, 
especially Hox cluster genes. Impacts of knockdown of 
individual core PRC2 components and EZH1/2-specific 
inhibitor were analyzed to understand the direct role of 
PRC2 in the management of H3K27me3 at Hox loci. 
Finally, MTF2 was identified as a key component in the 
regulation of transcription at Hox loci as well as in the 
accumulation of H3K27me3 in the absence of PRC2. 
RESULTS
Differentiation of F9 cells to primitive endoderm
To explore transcriptional changes during 
differentiation, F9 cells were treated with RA for 3 days 
(D3) and compared with control (D0, F9 cells without RA 
treatment). The efficiency of differentiation was examined 
by qRT PCR using endodermal marker genes such as 
Gata4, Gata6, Sox17, and Dab2 as primers. F9 cells 
were confirmed to be properly differentiated (Figure 1A). 
Representative decrease in the expression of genes such 
as Enox1, Bmp4, Dab1, and Rxrg was validated upon 
RA differentiation. Genome-wide expression profiles 
in F9 cells were analyzed by mRNA-Seq at D0 and D3. 
Chromosome-wide profiles and expression levels of 
Hox cluster genes are shown in Figure 1B. Noticeable 
changes at D3 were detected for Hox cluster genes (Hox 
B in Figure 1B, others in Supplementary Figure 1A–1C). 
The expression of Hox A cluster gene was also high while 
expression levels of Hox C and D cluster genes were 
relatively low (Supplementary Figure 1A–1C). The gene 
induction by RA treatment was validated by qRT PCR with 
Hox B cluster genes (Figure 1C). At D3, 1,753 genes were 
up-regulated while 944 genes were down-regulated with 
a threshold of absolute fold change > 2 and FDR < 10–3. 
During differentiation, the top 10 gene ontology (GO) 
terms were identified with high significance. Among them, 
genes involved in collagen fibril organization, extracellular 
matrix disassembly, and vacuolar protein processing 
were ranked in the top three GO terms (Figure 1D). 
These results suggest that RA treatment could differentiate 
F9 cells to primitive endoderm and highly induce the 
transcription of the Hox gene cluster. 
Enrichment profiles of EZH2 and H3K27me3 at 
Hox loci during differentiation 
During differentiation, the relationship between the 
level of H3K27me3 and occupancy of PRC2 components 
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Figure 1: RA differentiates F9 cells to primitive endodermal cells. (A) qRT PCR analysis for expression levels of primitive 
endodermal marker genes at D3 relative to those at D0 (left panel) and downregulation of genes at D3 compared to those at D0 (right 
panel). The y-axis represents fold expression level normalized by taking the expression of D0 as 1. Error bars represent mean ± SD of 
three biological replicates. *P < 0.05, **P < 0.01, ***P < 0.001 by Student’s two-tailed t-test. For all bars, P values were less than 0.001 unless 
otherwise specified. (B) An overall view of genomic expression at D0 and D3. The top panel shows entire genes on whole chromosomes. The 
bottom panel shows Hox B cluster genes. (C) Verification of relative expression changes of Hox B cluster genes in RA differentiating cells 
by qRT PCR. Utf1 was used as a control. Error bars represent mean ± SD of three biological replicates. *P < 0.05, **P < 0.01, ***P < 0.001 
by Student’s two-tailed t-test. For all bars, P values were less than 0.001 unless otherwise specified. (D) GO analysis of up-regulated genes 
at D3 compared to those at D0. Bars represent –log10 of p-values.
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was explored. A comparative analysis between D0 and 
D3 showed a decrease in the enrichment of EZH2 and 
H3K27me3 at D3. The degree of decrease in EZH2 
was more substantial compare to that of H3K27me3 
(Figure 2A). Next, EZH2 and H3K27me3 enriched regions 
showing decrease in enrichment at D3 were divided into 
three groups: 2,908 regions with both decrease of EZH2 
and H3K27me3, 971 regions with decrease of EZH2 
only, and 4,101 regions with decrease of H3K27me3 only 
(Figure 2B). Co-occupied regions with both decrease of 
EZH2 and H3K27me3 showed positive correlation in 
enrichment patterns in the whole genome level and at the 
localized peaks (Supplementary Figure 2A, 2B). EZH2 
and H3K27me3 were relatively depleted at D3 compared 
to those at D0 (Supplementary Figure 2C). 
Consistent with the fact that Hox B cluster 
genes were transcriptionally induced by RA, histone 
methyltransferase EZH2 enrichment was decreased and 
patterns of H3K27me3 were strongly depressed at Hox 
B loci (Figure 2C). The decrease in enrichment of EZH2 
and H3K27me3 was confirmed by ChIP qPCR (Figure 
2D, 2E). A similar reduction was observed for SUZ12 and 
EED at Hox B loci (Supplementary Figure 2D, 2E). Other 
Hox cluster genes such Hox A, C, and D also showed 
sharp decrease in the binding of EZH2 and introduction 
of H3K27me3 (Supplementary Figure 2F–2H). As 
expected, the level of active histone mark H3K4me3 was 
augmented at Hox B genes (Figure 2F). Genes occupied 
commonly by EZH2 and H3K27me3 were related to 
the following biological processes: pattern specification 
process, regionalization, cell fate commitment, and so on 
(Supplementary Figure 2I). However, these events were 
not detected in other chromatin regions occupied only by 
H3K27me3 (Supplementary Figure 2J). Taken together, 
these results suggest that Hox genes are repressed by 
PRC2 through H3K27me3 in undifferentiated cells 
and RA signal can induce the increase of H3K4me3 for 
transcriptional activation.
Unusual accumulation of H3K27me3 at Hox loci 
by down-regulation of EZH2
PRC2 plays a critical role in the transcriptional 
regulation of Hox genes during differentiation [8]. To 
further investigate the functional role of PRC2 in F9 cells, 
individual core PRC2 components Ezh2, Suz12, and Eed 
were knocked down using short hairpin RNA (shRNA) 
(Supplementary Figure 3A). Although the global level 
of H3K27me3 was strongly decreased, each PRC2 
component was not completely depleted (Figure 3A). The 
expression levels of all PRC2 components (EZH2, SUZ12, 
and EED) were repressed by individual shRNA. The 
expression of EZH2 was also decreased by knockdown 
of either Suz12 or Eed (Figure 3A). A substantial decrease 
in PRC2 enrichment at Hox B loci was confirmed by 
ChIP qPCR when Ezh2, Suz12, or Eed was independently 
knocked down (Figure 3B, Supplementary Figure 3B, 3C). 
Contrast to the down-regulation of H3K27me3 level 
corresponding to decreased EZH2 binding at Hox loci 
during differentiation (Figure 2D), the deposition of 
H3K27me3 was dramatically elevated even with partial 
depletion of EZH2 (Figure 3C). These changes in Hox B 
genes were further confirmed by qPCR (Figure 3D). The 
same effect was also observed in Suz12 or Eed knockdown 
experiments (Supplementary Figure 3D–3F). Other Hox 
A, C, and D cluster genes also conceded an increase of 
H3K27me3 with depletion of each PRC2 component 
(Supplementary Figure 3G–3I). Regions significantly 
enriched with H3K27me3 in F9 cells treated with shRNA 
for Ezh2, Suz12, or Eed (over 2-fold increase compared to 
control shRNA) were found to be as 2,629, 926, and 2,340, 
respectively. Most of them were overlapped (Figure 3E). 
A total of 925 common H3K27me3-enriched regions 
were subjected to GO analysis. Genes maintaining high 
levels of H3K27me3 by perturbation of PRC2 complex 
were primarily categorized into biological processes 
such as pattern specification process, regulation of 
transcription from RNA polymerase II promoter, and 
organ morphogenesis (Figure 3F). The unexpected 
accumulation of H3K27me3 at Hox loci might be due 
to selective histone methylation by some residual PRC2 
complex or the action of EZH1 known to complement 
EZH2 [10]. When treating F9 cells with UNC 1999, an 
EZH1/2 inhibitor, for 96 h, global level of H3K27me3 
was strongly decreased in a dose-dependent manner. 
It was almost completely abolished by UNC 1999 at a 
concentration of 2 µM compared with UNC 2400, a close 
analog of UNC 1999 as a negative control (Supplementary 
Figure 3J). The strong decrease in global H3K27me3 level 
was due to the inhibition of EZH1/2 activity by treating 
UNC 1999. However, the level of H3K27me3 showed a 
significant increase at all Hox B cluster genes, indicating 
that EZH1 and/or EZH2 might not be absolutely needed 
for introducing methylation at histone H3 lysine 27 
(Figure 3G). Moreover, the reduction in any of core PRC2 
components could lead to the decrease of PRC2 binding 
to target sites and give rise to an unexpected hike of 
H3K27me3 (Supplementary Figure 3D, 3G–3I, 3K–3M, 
Figure 3C). Taken together, these observations reveal a 
novel regulatory role of PRC2 in the maintenance of a 
specific level of H3K27me3 at Hox loci. 
Hox cluster expression is not affected by PRC2 
interference 
To investigate the role of PRC2 in the transcriptional 
control at D0, gene expression profiles of Ezh2, Suz12, 
and Eed knockdown cells were analyzed by RNA-Seq. 
Gene Set Enrichment Analysis (GSEA) was performed 
using top 500 genes where H3K27me3 was increased 
upon PRC2 knockdown (Figure 4A). Expression 
changes of genes with elevated H3K27me3 upon PRC2 
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Figure 2: Displacement of H3K27me3 and PRC2 during cellular differentiation induced by RA. (A) Colored scatterplots 
of bins with length of 1 kb occupied by EZH2 (left) and H3K27me3 (right) at D0 and D3. (B) Heatmaps of ChIP-Seq signals ± 4 kb from 
the center of regions enriched with EZH2 and H3K27me3 common regions, EZH2 specific regions, and H3K27me3 specific regions (left). 
Metagene plots depicts the average pattern of EZH2 and H3K27me3 (right). (C) A genomic view showing that both EZH2 and H3K27me3 
were strongly decreased at D3 compared to those at D0. Verification of the effect of (D) EZH2 or (E) H3K27me3 displacement from Hox 
B cluster genes by ChIP qPCR. Osteopontin was used as a negative control. (F) Accumulation of H3K4me3 confirmed by ChIP qPCR in 
differentiating cells. ChIP results are shown relative to the input percentage. Error bars represent mean ± SD of three biological replicates. 
*P < 0.05, **P < 0.01, ***P < 0.001 by Student’s two-tailed t-test. For all bars, P values were less than 0.001 unless otherwise specified. 
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Figure 3: Depletion of Ezh2 induce H3K27me3 at Hox loci. (A) Western blot analysis of cellular components after knockdown 
of Ezh2, Suz12, and Eed. H3K27me3 was strongly decreased. GAPDH and H3 were used as loading controls. Star (*) denotes decrease 
in protein expression. (B) ChIP qPCR of EZH2 binding to Hox B cluster genes in Ezh2 knockdown. Osteopontin was used as a negative 
control. Error bars represent mean ± SD of three biological replicates. *P < 0.05, **P < 0.01, ***P < 0.001 by Student’s two-tailed t-test. For 
all bars, P values were less than 0.001 unless otherwise specified. (C) A genomic view of H3K27me3 with increased H3K27me3 at Hox B 
loci in Ezh2 knockdown. (D) Verification with ChIP qPCR. Osteopontin was used as a negative control. Shlf2 and Shbg were used as controls 
to show decreased H3K27me3 in Ezh2 knockdown. Error bars represent mean ± SD of three biological replicates. *P < 0.05, **P < 0.01, 
***P < 0.001 by Student’s two-tailed t-test. For all bars, P values were less than 0.001 unless otherwise specified. (E) A Venn diagram 
showing regions enriched with H3K27me3 upon knockdown of Ezh2, Suz12, and Eed. (F) GO analysis of regions with enrichment of 
H3K27me3 in all three conditions. A total of 925 common H3K27me3-enriched regions were used for GO analysis. Bars represent -log10 of 
p-values. (G) ChIP qPCR showing the increase in enrichment of H3K27me3 after inhibition of EZH1/2 by UNC1999. UNC2400 was used 
as control. Error bars represent mean ± SD of three biological replicates. *P < 0.05, **P < 0.01, ***P < 0.001 by Student’s two-tailed t-test. 
For all bars, P values were less than 0.001 unless otherwise specified. 
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knockdown were negatively correlated with down-
regulation of Ezh2 (Enrichment score, ES= −0.68) or 
Eed (ES= −0.69). However, the enrichment score upon 
Suz12 knockdown was positive (ES = 0.68). Despite 
high enrichment of H3K27me3, many genes displayed 
high expression in Suz12-KO cells. A total of 688 up-
regulated genes compared to control at each knockdown 
(169 for Ezh2, 607 for Suz12, and 107 for Eed) were 
identified with a threshold of expression fold change > 2 
and FDR < 10–3. Hierarchical clustering with relative 
distance less than 0.2 could classify 237 genes dependent 
on Suz12 (Figure 4B). Their major functions are involved 
in positive regulation of fibroblast proliferation, positive 
regulation of cardiac muscle cell proliferation, central 
nervous system development, and so on (Figure 4C). The 
expression of primitive endodermal marker genes was 
only activated in Suz12 knocked-down cells. Accordingly, 
their transcription levels were confirmed by RNA-Seq 
and qRT PCR (Figure 4D and 4E). The reduction of 
any PRC2 component further decreased the expression 
of Hox B cluster genes (Figure 4F, 4G, Supplementary 
Figure 4A, 4B). Similarly, the expression of Hox B genes 
during differentiation was reduced in knocked-down cells 
(Supplementary Figure 4C). Like Hox B cluster genes, 
Hox A, C, and D cluster genes were not increased in 
PRC2 depleted cells either (Supplementary Figure 4D–
4F). The removal of core PRC2 components induced the 
impairment in the transcriptional activation of Hox genes. 
Although Suz12 knockdown resulted in the activation of 
primitive endodermal marker genes, it was not related to 
the expression of Hox genes.
Novel regulatory role of MTF2 in the absence of 
SUZ12
MTF2/ PCL2, an auxiliary component of the PRC2 
complex, can enhance histone methyltransferase activity 
of PRC2 and repress the transcription of Hox genes 
[20, 30]. To examine the potential role of MTF2 in the 
regulation of H3K27me3 and Hox genes’ expression in 
D0 F9 cells, Mtf2 was down-regulated by shRNA in wild-
type cells (WT) and Suz12 knockout cells (Suz12-KO). 
The expression of MTF2 was partially reduced in Suz12-
KO. The effect of Mtf2 shRNA was similar in both WT 
and Suz12-KO (Figure 5A). Protein level of SUZ12 was 
not changed regardless of MTF2 expression. In contrast, 
mRNA level of Mtf2 in Suz12-KO was comparable to 
that in WT (Supplementary Figure 5A). The binding 
of MTF2 to Hox B genes was significantly decreased 
after Mtf2 knockdown (Figure 5B). Furthermore, 
the recruitment of MTF2 to Hox B loci was strongly 
decreased in Suz12-KO, implying that MTF2 should be 
recruited to an intact PRC2 complex depending on SUZ12 
(Figure 5B). Subsequently, the binding of SUZ12 was 
strongly curtailed in Suz12-KO as expected. However, 
it was also significantly decreased with the reduction of 
MTF2 at Hox B genes (Supplementary Figure 5B). The 
global level of H3K27me3 was completely diminished 
in Suz12-KO, but not changed with MTF2 depletion 
(Figure 5A). Compared to WT, the level of H3K27me3 
at Hox B loci was enhanced in Suz12-KO (green bar), 
but not changed in Mtf2 knockdown cells (light blue vs. 
red) (Figure 5C). Surprisingly, knockdown of Mtf2 could 
counteract the effect of depletion of Suz12 (dark blue vs. 
green). Moreover, along with restoration of H3K27me3 
levels in WT, Hox B cluster genes showed high 
transcriptional induction in Suz12-KO+Mtf2-sh (Figure 
5D). Subsequently, high levels of H3K4me3 were also 
confirmed in Suz12-KO+Mtf2-sh (Figure 5E). Although 
eminent H3K4me3 was maintained in Suz12-KO, it 
seemed to be insufficient to activate Hox B cluster genes 
in the presence of MTF2. Collectively, these observations 
suggest that MTF2 could indirectly control the enrichment 
of H3K27me3 in the absence of PRC2.
DISCUSSION
In this study, F9 cells were differentiated to 
primitive endodermal cells by RA treatment and induced 
the expression of most Hox cluster genes. The activation 
of Hox genes was accompanied by reduced binding of 
core PRC2 components EZH2, SUZ12, and EED along 
with repressive histone marker H3K27me3. Depending 
on enrichment patterns of EZH2 and H3K27me3 at D0 
and D3, genomic regions could be divided into three 
groups (decrease of both EZH2 and H3K27me3, decrease 
of EZH2 only, and decrease of H3K27me3 only). This 
observation suggests that the installment of H3K27me3 
is not solely dependent on EZH2. Some unknown factors 
may contribute to the assembly of H3K27me3 at localized 
regions. Hox genes were included in the first group which 
showed strong decrease in the enrichment of PRC2 and 
H3K27me3 at D3 (Figure 2C, Supplementary Figure 
2D–2H). Due to the substantial decrease in the binding 
of PRC2 and H3K27me3 at Hox loci, it was irrational 
to perform knockdown experiments in D3 cells. To 
investigate the deposition of H3K27me3 at Hox loci 
in D0 cells, we knocked down the expression of core 
PRC2 components Ezh2, Suz12, and Eed by specific 
shRNA independently. The global level of H3K27me3 
was strongly decreased by the reduction of all core 
components. Downregulation of SUZ12 and EED reduced 
the expression of EZH2. However, knockdown of Ezh2 
was unable to decrease the expression of SUZ12 or 
EED. This result is consistent with previous observations 
showing that the stability of EZH2 protein is dependent on 
SUZ12 and EED [31, 32]. SUZ12 interacts and stabilizes 
EZH2 by its VEFS (VRN2, EMF2, FIS2 and Su(z)12) 
domain present at its C -terminal region by preventing 
proteasome-dependent degradation without affecting 
the expression of EED [15, 33]. The expression of EED 
was not affected by the reduction of EZH2 or SUZ12 
Oncotarget26579www.oncotarget.com
Figure 4: Transcriptome alterations in PRC2 depleted cells. (A) GSEA for overall expression changes of the top 500 genes 
with H3K27me3 enhancement upon knockdown of Ezh2 (left), Suz12 (middle), and Eed (right). ES: enrichment score; NES: normalized 
enrichment score. (B) Heatmaps displaying the expression level of up-regulated genes at each knockdown compared to the control. (C) GO 
analysis for up-regulated genes specific to Suz12 knockdown. Bars represent -log10 of p-values. (D) Genomic views of primitive endodermal 
marker genes. (E) Verification with qRT PCR for endodermal marker genes. Error bars represent mean ± SD of three biological replicates. 
*P < 0.05, **P < 0.01, ***P < 0.001 by Student’s two-tailed t-test. For all bars, P values were less than 0.001 unless otherwise specified. (F) 
A genomic view of Hox B loci showing no expression in Ezh2 knockdown cells compare to control. (G) Verification with qRT PCR for Hox 
B cluster genes. SatB2 was used as a control. Error bars represent mean ± SD of three biological replicates. ND: Not Detected.
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Figure 5: MTF2 regulates H3K27me3 at Hox B loci in the absence of SUZ12. (A) Western blot assay after the knockdown of 
Mtf2 in WT and Suz12-KO. H3K27me3 did not change with knockdown of Mtf2, but disappeared with Suz12 knockout. GAPDH and H3 
were used as loading controls. ChIP qPCR for (B) MTF2 and (C) H3K27me3 at Hox B loci upon knockdown of Mtf2 in WT and Suz12-KO. 
Osteopontin was used as a negative control. H3K27me3 was significantly decreased in Suz12 and Mtf2 double depletion compared to that 
in Suz12-KO. (D) qRT PCR for the expression of Hox B cluster genes. (E) ChIP qPCR for H3K4me3 of Hox B cluster genes. Error bars 
represent mean ± SD of three biological replicates. *P < 0.05, **P < 0.01, ***P < 0.001 by Student’s two-tailed t-test. For all bars, P values 
were less than 0.001 unless otherwise specified. 
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in F9 cells. In the absence of EZH2 or SUZ12, PRC1 
components BMI or RING1B may increase the stability 
of EED as both PRC1 components compete with EZH2 
for EED binding. At higher concentration, they can even 
abrogate the enzymatic activity of PRC2 [32]. PRC2 also 
contains many sub-stoichiometric components. These 
auxiliary components of PRC2 may also play some 
roles in the stability of the individual core members. For 
example, expression levels of SUZ12 protein and mRNA 
are altered with knockdown and overexpression of Pcl3 
(Polycomb-like 3) protein without affecting the stability 
of EZH2 or EED [34]. 
ChIP-Seq results showed a strong accumulation of 
H3K27me3 at Hox loci in PRC2 knockdown cells. Such 
increase in the enrichment of H3K27me3 was unexpected 
because not only global level of H3K27me3 was strongly 
reduced upon PRC2 knockdown, but also the binding 
of core components was significantly decreased by 
treatment with shRNA. Genes showing elevated levels 
of H3K27me3 were involved developmental processes 
such as organ morphogenesis, neurogenesis, cell fate 
commitment, and neuronal differentiation. Previous studies 
have reported that Ezh1 can directly compensate the role 
of Ezh2 in its absence by making a different complex 
called PRC2-EZH1 which contributes to localized level of 
H3K27me3 [10, 11]. To assess the potential role of EZH1 
in the accumulation of H3K27me3 at Hox loci, F9 cells 
were treated with EZH1/2-specific inhibitor. The level 
of H3K27me3 was globally decreased with inhibition 
of EZH1/2. However, it is gene-specifically increased, 
especially at the Hox cluster genes. It is quite comparable 
to the accumulation of H3K27me3 at the same loci upon 
PRC2 knockdown. This observation ruled out the potential 
involvement of EZH1 in the absence of EZH2. De-
repression of PRC2 target genes has been demonstrated in 
Eed -/- ESCs and Suz12-KO cells [3, 16, 17, 35], although 
other groups have claimed that KO of PRC2 does not 
lead to significant transcriptional changes in mESCs [36]. 
It seems that PRC2 can repress the expression of target 
genes in a cell type-specific manner. Functional reduction 
of PRC2 in F9 cells was unable to induce the expression 
of Hox genes. In contrast with Ezh2 and Eed, knockdown 
of Suz12 transcriptionally induced some genes, even in the 
presence of high level of H3K27me3. This observation 
was quite unexpected. However, the same outcome has 
been observed previously. It has been concluded that 
H3K27me3 cannot inhibit the transcription of genes even 
in the presence of PcG proteins [2, 16]. SUZ12 is the major 
PRC2 member that can sustain the stability of PRC2. As 
mentioned earlier, the loss of SUZ12 can decrease the 
expression of EZH2. Thus, we hypothesized that the same 
might happen for other components. They might facilitate 
the expression of PRC2 target genes. Knockout of Suz12 
partially decreased the global level of MTF2. We could 
not exclude the possibility that reduced MTF2 might have 
a regulatory role in the activation of target genes. It is 
also possible that SUZ12 protein can physically block the 
recruitment of transcription machinery. Thus, the reduction 
of SUZ12 might pave the way for transcriptional induction. 
Although the reduction of SUZ12 induced the expression 
of some genes, it was unable to induce the expression of 
Hox genes. Our observations are completely opposite to 
the classical concept that PRC2 is the major repressive 
complex in the regulation of Hox gene transcription 
through H3K27me3 [37, 38]. 
By combining with sub-stoichiometric components, 
PRC2 can form two different complexes: PRC2-JARID 
and PRC2-MTF2. In Jarid2 knockdown cells, core 
components of PRC2 are recruited and the increase of 
H3K27me3 is detected at target genes [39]. This increase 
might be due to the potential involvement of PRC2-MTF2. 
PCL is also known to contribute to the induction of high 
levels of H3K27me3 at PRC2 target genes [20]. Here, we 
investigated the interlink between MTF2 and PRC2 core 
subunits. Down-regulation of Mtf2 did not affect the global 
level of SUZ12 or H3K27me3. However, the expression 
of MTF2 was partially related to the depletion of Suz12. 
At Hox B cluster genes, the binding of MTF2 was fully 
dependent on SUZ12. Double inhibition of MTF2 and 
SUZ12 re-established the level of H3K27me3 comparable 
to WT and induced the expression of Hox B cluster genes 
with deposition of active histone marker H3K4me3. 
Based on these observations, we speculate that remaining 
MTF2 in Suz12-KO cells might boost the enrichment of 
H3K27me3 at Hox genes through unexplored mechanism. 
PRC2 is a gigantic complex. Auxiliary subunits of this 
complex could also play a vital role in the assembly of 
H3K27me3. Recently, PRC2 has been classified into 
two complexes: PRC2.1 and PRC2.2. In addition to 
core PRC2 components (EZH2, SUZ12, EED, and 
RbAp46/48), PRC2.1 could be structured by the addition 
of one of PCL homologs (PHF1, MTF2, or PHF19) with 
EPOP or C10orf12. PRC2.2 could be constituted by the 
combination of core components together with AEBP2 
and JARID2. Although these three PCL paralogs have 
a close evolutionary relationship, they regulate PRC2 
activity in different manners [40, 41]. The role of AEBP2 
is also compelling as it impedes the level of H3K27me3 
at PRC2 target genes. The loss of AEBP2 can reduce the 
association of JARID2 with the PRC2 complex and pave 
the way for inclusion of MTF2 to form a hybrid complex 
that could not be detected in wild-type setting [41, 42]. It 
is possible that AEBP2 and MTF2 could compete for the 
regulation of H3K27me3 at PRC2 target genes. Despite 
different combinations of core PRC2 members with sub-
stoichiometric components, it is possible that sub PRC2 
complexes can control the enrichment of H3K27me3 at 
gene-specific levels.
Based on these observations, we could establish 
a relationship between PRC2 and MTF2 in F9 cells. 
The proposed model is shown in Figure 6. During 
differentiation, PRC2 and H3K27me3 are displaced, 
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resulting in the activation of Hox genes and accumulation 
of H3K4me3. In undifferentiated cells, PRC2 can maintain 
H3K27me3 at Hox cluster genes. However, displacement 
of PRC2 may trigger MTF2 to accumulate H3K27me3 
at target sites. Simultaneous down-regulation of Mtf2 
and Suz12 releases the enrichment of H3K27me3 and 
provides a permissive environment for the introduction of 
H3K4me3 to activate Hox genes expression. Collectively, 
MTF2 associated with PRC2 might secure the repressive 
function of PRC2 in undifferentiated cells. But for some 
reason, the impairment of PRC2 reverses the chromatin 
state into activated form by introducing H3K4me3 at 
target sites. Our finding could be pertinent to identify the 
mechanism underlying the unusual hyper- or hypo-activity 
of transcription factors controlled by PRC in chromatin 
context. 
MATERIALS AND METHODS
Cell culture
Mouse F9 teratocarcinoma cells were obtained from 
American Type Culture Collection (ATCC CRL-1720, 
USA) and grown using standard tissue culture protocol. 
Cells were cultured on 0.1% gelatin (Sigma, USA) in 
Dulbecco’s Modified Eagles Medium (WelGENE Inc, 
Korea) supplemented with 10% FBS (Fetal Bovine Serum; 
WelGENE Inc, Korea) and 100 µg/ml of penicillin-
streptomycin (WelGENE Inc, Korea) at 37° C with 5% 
CO2 atmosphere. For differentiation, cells were treated 
with 1 µM retinoic acid (RA, Sigma, USA) for 72 h. 
Untreated cells were regarded as D0. For gene knockdown 
experiments, shRNA viral particles containing media were 
added to F9 cells and incubated at 37° C with 5% CO2 
atmosphere for 48 h. 
Plasmids construction and generation of 
transgenic cells
shRNA sequences targeting Ezh2, Suz12 and Eed 
(Supplementary Table 1) were designed using public 
TRC Portal website (https://portals.broadinstitute.org/
gpp/public/seq/search). HEK293T cells were transiently 
transfected with pLK0.1-puro harboring shRNA, 
delta8.91, and pMD2.G plasmids at 3:2:1 ratio using 
Lipofectamine2000 (Invitrogen, USA). At six hours after 
Figure 6: Proposed model for the regulatory role of PRC2 in undifferentiated and differentiated F9 cells. Differentiation 
of F9 cells with RA displaces PRC2 as well as H3K27me3. It induces the transcription of Hox genes and the accumulation of H3K4me3. 
Conversely, the reduction of PRC2 components induces the accumulation of H3K27me3 without transcriptional induction of Hox genes. 
MTF2 is partially stable in the absence of SUZ12. Additional reduction of the remaining MTF2 brings back H3K27me3 with transcriptional 
induction of Hox genes and enrichment of H3K4me3.
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transfection, media were changed, and viral particles 
were harvested after 48 h and 72 h of culture and filtered. 
F9 cells were transduced with shRNA viral particles for 
48 h. The suz12 knockout was performed as described 
previously [43] with slight modifications. Briefly, single 
guide RNA (sgRNA) (TCGGGCGGCAAATCCGGCGG) 
oligonucleotides corresponding to target protospacers were 
cloned in pSpCas9(BB)-2A-Puro (PX459) (Addgene, 
USA). Stable cell lines were selected by treating cells with 
puromycin for 3 days. Single KO cells were amplified for 
further experiments.
Total RNA Isolation and gene expression analysis 
by qRT-PCR
Total RNA was isolated using TRI-solution 
(Bio Science, Korea) and treated with DNase I (NEB, 
USA). Purified RNA was reverse transcribed using 
Reverse transcriptase SuperScript III (Invitrogen, USA). 
PCR amplification was performed with the following 
conditions: initial denaturation at 94° C for 5 min followed 
by 30 cycles of 94° C for 30 sec, 60° C for 30 sec, and 72 
for 30 sec. qRT-PCR was performed using SYBR Premix 
Ex Taq (Tli RNaseH Plus) (Takara, Japan). Primers used 
for RT PCR are listed in Supplementary Table 2.
Western blot analysis
SDS-PAGE and protein transfer were performed 
using the standard protocol. Antibodies used in western 
blot are listed in Supplementary Table 3.
Preparation of chromatin and 
immunoprecipitation 
Chromatin immunoprecipitation (ChIP) was 
performed as described previously [44, 45]. ChIP-
qPCR was performed using SYBR Premix Ex Taq 
(Takara, Japan). Antibodies used in ChIP are listed in 
Supplementary Table 4.
Data analysis of ChIP-Seq and RNA-Seq
Data for ChIP-Seq and RNA-Seq were obtained 
using Illumina Hiseq 2500. ChIP-Seq and RNA-Seq data 
were analyzed as described previously [45]. Additionally, 
gene set enrichment assay (GSEA) [46] was performed to 
reveal overall expression changes for a priori defined set 
of genes under certain conditions. The defined set included 
top 500 genes near which H3K27me3 was increased upon 
PRC2 KD. Differentially expressed genes were identified 
by edgeR-3.16.5 [47] based on absolute fold change > 2 
and FDR < 10–3. Enrichr [48] was used to investigate 
GO terms enriched with genes of interest. Genomic 
views were explored with WashU Epigenome Browser 
[49]. R-3.4.1 (http://www.r-project.org) was used to plot 
various graphs unless specifically noted. Sequencing data 
produced were deposited into Gene Expression Omnibus 
(GEO) at the National Center for Biotechnical Information 
(NCBI) (GSE111147).
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